Up to date, the expression of EIF4G1 was up‐regulated in nasopharyngeal carcinoma, breast cancer, ovarian cancer and squamous cell lung carcinoma, but there is no report about EIF4G1 being involved in signalling pathways in NSCLC. Here, EIF4G1 is linked to ovarian cancer.